Down-regulation of Filamin Ainteracting protein 1-like is associated with promoter methylation and an invasive phenotype in breast, colon, lung and pancreatic cancers

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Kwon, Mijung ^a   Lee, Soo Jin ^a   Reddy, Srilakshmi ^a   Rybak, Yevangelina ^a   Adem, Asha ^a   Libutti, Steven K ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CELL PROTEIN; DNA; FILAMIN A INTERACTING PROTEIN 1 LIKE; GENOMIC DNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL INVASION ASSAY; COLON CANCER; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EPITHELIUM CELL; GENETIC TRANSFECTION; HISTOLOGY; HUMAN; HUMAN CELL; LUNG CANCER; PANCREAS CANCER; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYTOKINES; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS;

EID: 84891910660     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082620     Document Type: Article

References (24)

1. Bravo-Cordero JJ, Hodgson L, Condeelis J (2012) Directed cell invasion and migration during metastasis. Curr Opin Cell Biol 24: 277-283. doi:10.1016/j.ceb.2011.12.004. PubMed: 22209238.
2. Kwon M, Hanna E, Lorang D, He M, Quick JS et al. (2008) Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy. Cancer Res 68: 7332-7341. doi: 10.1158/0008-5472. CAN-08-1087. PubMed: 18794120.
3. Burton ER, Gaffar A, Lee SJ, Adeshuko F, Whitney KD et al. (2011) Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer. Mol Cancer Res 9: 1126-1138. doi: 10.1158/1541-7786.MCR-11-0162. PubMed: 21693594.
4. Xie C, Gou ML, Yi T, Deng H, Li ZY et al. (2011) Efficient inhibition of ovarian cancer by truncation mutant of FILIP1L gene delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels. Hum Gene Ther 22: 1413-1422. doi:10.1089/hum.2011.047. PubMed: 21513424.
5. Mok SC, Wong KK, Chan RK, Lau CC, Tsao SW et al. (1994) Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol 52: 247-252. doi:10.1006/gyno. 1994.1040. PubMed: 8314147. (Pubitemid 24064379)
6. Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J et al. (2002) Gene expression in epithelial ovarian carcinoma. Oncogene 21: 6289-6298. doi:10.1038/sj.onc.1205785. PubMed: 12214269.
7. Quaye L, Dafou D, Ramus SJ, Song H, Gentry-Maharaj A et al. (2009) Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival. Hum Mol Genet 18: 1869-1878. doi:10.1093/hmg/ddp107. PubMed:19270026.
8. Notaridou M, Quaye L, Dafou D, Jones C, Song H et al. (2011) Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer, 128: 2063- 74. PubMed: 20635389.
9. Schwarze SR, DePrimo SE, Grabert LM, Fu VX, Brooks JD et al. (2002) Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J Biol Chem 277: 14877-14883. doi: 10.1074/jbc.M200373200. PubMed: 11836256. (Pubitemid 34952561)
10. Schwarze SR, Fu VX, Desotelle JA, Kenowski ML, Jarrard DF (2005) The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. Neoplasia 7: 816-823. doi: 10.1593/neo.05250. PubMed: 16229804.
11. Desotelle J, Truong M, Ewald J, Weeratunga P, Yang B et al. (2013) CpG Island Hypermethylation Frequently Silences FILIP1L Isoform 2 Expression in Prostate Cancer. J Urol 189: 329-335. doi:10.1016/j.juro. 2013.02.363. PubMed: 23174249.
12. Ehrich M, Turner J, Gibbs P, Lipton L, Giovanneti M et al. (2008) Cytosine methylation profiling of cancer cell lines. Proc Natl Acad Sci U S A 105: 4844-4849. doi:10.1073/pnas.0712251105. PubMed: 18353987. (Pubitemid 351753834)
13. Radpour R, Haghighi MM, Fan AX, Torbati PM, Hahn S et al. (2008) High-throughput hacking of the methylation patterns in breast cancer by in vitro transcription and thymidine-specific cleavage mass array on MALDI-TOF silico-chip. Mol Cancer Res 6: 1702-1709. doi: 10.1158/1541-7786.MCR-08-0262. PubMed: 19010818.
14. Radpour R, Kohler C, Haghighi MM, Fan AX, Holzgreve W et al. (2009) Methylation profiles of 22 candidate genes in breast cancer using highthroughput MALDI-TOF mass array. Oncogene 28: 2969-2978. doi: 10.1038/onc.2009.149. PubMed: 19503099.
15. Vanaja DK, Ehrich M, Van den Boom D, Cheville JC, Karnes RJ et al. (2009) Hypermethylation of genes for diagnosis and risk stratification of prostate cancer. Cancer Invest 27: 549-560. doi: 10.1080/07357900802620794. PubMed: 19229700.
16. Khumalo T, Reusch U, Knackmuss S, Little M, Veale RB et al. (2013) Adhesion and Invasion of Breast and Oesophageal Cancer Cells Are Impeded by Anti-LRP/LR-Specific Antibody IgG1-iS18. PLOS ONE 8: e66297. doi:10.1371/journal.pone.0066297. PubMed: 23823499.
17. Mazzanti CM, Tandle A, Lorang D, Costouros N, Roberts D et al. (2004) Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells. Genome Res 14: 1585-1593. doi:10.1101/gr.2552804. PubMed: 15289477. (Pubitemid 39193409)
18. Tandle AT, Mazzanti C, Alexander HR, Roberts DD, Libutti SK (2005) Endothelial monocyte activating polypeptide-II induced geneexpression changes in endothelial cells. Cytokine 30: 347-358. doi: 10.1016/j.cyto.2005.01.020. PubMed: 15935955. (Pubitemid 40780967)
19. Conne B, Stutz A, Vassalli JD (2000) The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med 6: 637-641. doi:10.1038/76211. PubMed: 10835679. (Pubitemid 30398786)
20. Parker R, Song H (2004) The enzymes and control of eukaryotic mRNA turnover. Nat Struct Mol Biol 11: 121-127. doi:10.1038/nsmb724. PubMed: 14749774. (Pubitemid 38146514)
21. Nagamine Y, Medcalf RL, Muñoz-Cánoves P (2005) Transcriptional and posttranscriptional regulation of the plasminogen activator system. Thromb Haemost 93: 661-675. PubMed: 15841310. (Pubitemid 40485401)
22. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J et al. (2011) Global quantification of mammalian gene expression control. Nature 473: 337-342. doi:10.1038/nature10098. PubMed: 21593866.
23. Vogel C, Marcotte EM (2012) Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13: 227-232. PubMed: 22411467.
24. Salari R, Wojtowicz D, Zheng J, Levens D, Pilpel Y et al. (2012) Teasing apart translational and transcriptional components of stochastic variations in eukaryotic gene expression. PLoS Comput Biol 8: e1002644. PubMed: 22956896.